Riskpilot← Back to searchSign inGet full accessTHROMBOLOGIC ApS
APSIn liquidationCVR 32299814Ny Vestergade 7DForskning og eksperimentel udvikling indenfor bioteknologi · NACE 721100Est. 2009— employees
Revenue 2012
DKK -2,9M
EBITDA margin
104.4%
Equity ratio
-31.4%
Financial strength
Net profit 2012
DKK -2,8M
| Revenue | DKK -2,9M | — |
| EBITDA | DKK -3M | — |
| Net profit | DKK -2,8M | — |
| Total assets | DKK 4,2M | — |
| Equity | DKK -1,3M | — |
| Employees | — | — |
Legal name
THROMBOLOGIC ApS
CVR number
32299814
Legal form
Anpartsselskab
NACE code
721100 · Forskning og eksperimentel udvikling indenfor bioteknologi
Founded
8. oktober 2009
Share capital
DKK 700.166
Employees
—
VAT registered
No
Audit selected
No
Last report
2012-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af likvidator.
Address
Ny Vestergade 7D
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 |
|---|---|
| Revenue | -2.905 |
| Staff expenses | -0 |
| EBITDA | -3.032 |
| Depreciation & amort. | -0 |
| EBIT | -3.032 |
| Net financials | -420 |
| Profit before tax | -3.452 |
| Tax | -660 |
| Net profit | -2.792 |
| Item | 2012 |
|---|---|
| Total assets | 4.237 |
| Equity | -1.332 |
| Long-term debt | 5.420 |
| Short-term debt | 149 |
| Total debt | 5.569 |
EBITDA margin
-303227300.0%
This company
15.8%
Market median
-1919160227% vs market
20122012
Equity ratio
-31.4%
This company
38.2%
Market median
-182% vs market
20122012
Return on equity
-279221200.0%
This company
18.4%
Market median
-1517506622% vs market
20122012
Net profit margin
-279221200.0%
This company
8.1%
Market median
-3447175409% vs market
20122012
Asset turnover
-0.69×
This company
1.12×
Market median
-162% vs market
20122012
Debt / equity
4.18×
This company
0.62×
Market median
-574% vs market
20122012
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PJ Chief Executive Officer | Chief Executive Officer | 2009 | — | — |
AM Management | Management | 2009 | — | — |
KH Unofficial title | Unofficial title | 2013 | — | — |
CS Management | Management | 2009 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2009 | — | — | |
| Chairman | 2009 | — | — | |
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2010 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of THROMBOLOGIC ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pär Johansson | Chief Executive Officer | 0 companies |
| Astrid Maria Karolina Rask | Management | 0 companies |
| Kristian Holte | Unofficial title | 0 companies |
| Caroline Sundorph Pontoppidan | Management | 0 companies |
| Karin Jexner Hamberg | Board of Directors | 0 companies |
| Leif Helth Jensen | Board of Directors | 0 companies |
| Stephan Christgau | Chairman | 0 companies |
| Jens William Kindtler | Board of Directors | 0 companies |
| Per Ingemar Johansson | Board of Directors | 0 companies |
| Per Sprøgel | Board of Directors | 0 companies |